Cargando…

Metformin treatment response is dependent on glucose growth conditions and metabolic phenotype in colorectal cancer cells

Cancer cells exhibit altered metabolism, a phenomenon described a century ago by Otto Warburg. However, metabolic drug targeting is considered an underutilized and poorly understood area of cancer therapy. Metformin, a metabolic drug commonly used to treat type 2 diabetes, has been associated with l...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alhourani, Abdelnour H., Tidwell, Tia R., Bokil, Ansooya A., Røsland, Gro V., Tronstad, Karl Johan, Søreide, Kjetil, Hagland, Hanne R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8131751/ https://www.ncbi.nlm.nih.gov/pubmed/34006970 http://dx.doi.org/10.1038/s41598-021-89861-6

Ejemplares similares

Author Correction: Metformin treatment response is dependent on glucose growth conditions and metabolic phenotype in colorectal cancer cells
por: Alhourani, Abdelnour H., et al.
Publicado: (2022)

Metabolic flux analysis of 3D spheroids reveals significant differences in glucose metabolism from matched 2D cultures of colorectal cancer and pancreatic ductal adenocarcinoma cell lines
por: Tidwell, Tia R., et al.
Publicado: (2022)

Aging, Metabolism, and Cancer Development: from Peto’s Paradox to the Warburg Effect
por: Tidwell, Tia R., et al.
Publicado: (2017)

Comparison of CpG Island Methylator Phenotype (CIMP) Frequency in Colon Cancer Using Different Probe- and Gene-Specific Scoring Alternatives on Recommended Multi-Gene Panels
por: Berg, Marianne, et al.
Publicado: (2014)

Assessment of clinically related outcomes and biomarker analysis for translational integration in colorectal cancer (ACROBATICC): study protocol for a population-based, consecutive cohort of surgically treated colorectal cancers and resected colorectal liver metastasis
por: Søreide, Kjetil, et al.
Publicado: (2016)

Improved pH-Responsive Release of Phenformin from Low-Defect Graphene Compared to Graphene Oxide
por: Alhourani, Abdelnour, et al.
Publicado: (2021)

Elevated microsatellite alterations at selected tetranucleotides in early‐stage colorectal cancers with and without high‐frequency microsatellite instability: same, same but different?
por: Watson, Martin M., et al.
Publicado: (2016)

Graphene-based phenformin carriers for cancer cell treatment: a comparative study between oxidized and pegylated pristine graphene in human cells and zebrafish
por: Alhourani, Abdelnour, et al.
Publicado: (2022)

Prevalence of PD-L1 expression is associated with EMAST, density of peritumoral T-cells and recurrence-free survival in operable non-metastatic colorectal cancer
por: Watson, Martin M., et al.
Publicado: (2020)

Elevated Microsatellite Alterations at Selected Tetranucleotides (EMAST) Is Not Attributed to MSH3 Loss in Stage I-III Colon cancer: An Automated, Digitalized Assessment by Immunohistochemistry of Whole Slides and Hot Spots()()
por: Watson, Martin M, et al.
Publicado: (2019)

Mitochondrial determinants of chemoresistance
por: Bokil, Ansooya, et al.
Publicado: (2019)

A template to quantify the location and density of CD3 + and CD8 + tumor-infiltrating lymphocytes in colon cancer by digital pathology on whole slides for an objective, standardized immune score assessment
por: Lea, Dordi, et al.
Publicado: (2021)

Increased hepatic mitochondrial FA oxidation reduces plasma and liver TG levels and is associated with regulation of UCPs and APOC-III in rats
por: Lindquist, Carine, et al.
Publicado: (2017)

Camptothecin and khat (Catha edulis Forsk.) induced distinct cell death phenotypes involving modulation of c-FLIP(L), Mcl-1, procaspase-8 and mitochondrial function in acute myeloid leukemia cell lines
por: Bredholt, Therese, et al.
Publicado: (2009)

A new live-cell reporter strategy to simultaneously monitor mitochondrial biogenesis and morphology
por: Hodneland Nilsson, Linn Iren, et al.
Publicado: (2015)

Corrigendum: A new live-cell reporter strategy to simultaneously monitor mitochondrial biogenesis and morphology
por: Hodneland Nilsson, Linn Iren, et al.
Publicado: (2016)

Time to halt perioperative chemotherapy for resectable colorectal liver metastasis?
por: Søreide, Kjetil
Publicado: (2021)

Genetic and Epigenetic Traits as Biomarkers in Colorectal Cancer
por: Berg, Marianne, et al.
Publicado: (2011)

Resection of asymptomatic primary tumour in unresectable stage IV colorectal cancer: time to move on from propensity matched scores to randomized controlled trials
por: Søreide, Kjetil
Publicado: (2016)

Can molecular biomarkers replace a clinical risk score for resectable colorectal liver metastasis?
por: Veen, Torhild, et al.
Publicado: (2017)

Acute mesenteric ischaemia
por: Fuglseth, Hanne, et al.
Publicado: (2023)

KRAS mutation in patients undergoing hepatic resection for colorectal liver metastasis: A biomarker of cancer biology or a byproduct of patient selection?
por: Søreide, Kjetil, et al.
Publicado: (2014)

Refining the Role of Pyruvate Dehydrogenase Kinases in Glioblastoma Development
por: Larrieu, Claire M., et al.
Publicado: (2022)

Opposite and dynamic regulation of the interferon response in metastatic and non-metastatic breast cancer
por: Lamsal, Apsana, et al.
Publicado: (2023)

Long-Term Follow-Up and Survivorship After Completing Systematic Surveillance in Stage I–III Colorectal Cancer: Who Is Still at Risk?
por: Veen, T., et al.
Publicado: (2015)

Spontaneous Transformation of Stem Cells In Vitro and the Issue of Cross-Contamination
por: Torsvik, Anja, et al.
Publicado: (2012)

Novel Points of Attack for Targeted Cancer Therapy
por: Røsland, Gro Vatne, et al.
Publicado: (2015)

Using Patient-Reported Outcome Measures for Improved Decision-Making in Patients with Gastrointestinal Cancer – the Last Clinical Frontier in Surgical Oncology?
por: Søreide, Kjetil, et al.
Publicado: (2013)

Blocking Aerobic Glycolysis by Targeting Pyruvate Dehydrogenase Kinase in Combination with EGFR TKI and Ionizing Radiation Increases Therapeutic Effect in Non-Small Cell Lung Cancer Cells
por: Dyrstad, Sissel E., et al.
Publicado: (2021)

Histopathological Growth Pattern in Colorectal Liver Metastasis and The Tumor Immune Microenvironment
por: Zaharia, Claudia, et al.
Publicado: (2022)

Three decades (1978–2008) of Advanced Trauma Life Support (ATLS™) practice revised and evidence revisited
por: Søreide, Kjetil
Publicado: (2008)

Trauma and the acute care surgery model – should it embrace or replace general surgery?
por: Søreide, Kjetil
Publicado: (2009)

The role of high-mobility group box-1 (HMGB-1) in the management of suspected acute appendicitis: useful diagnostic biomarker or just another blind alley?
por: Søreide, Kjetil
Publicado: (2011)

Emergency surgery over 111 years: are we still at a crossroads or ready for emergency surgery 2.0?
por: Søreide, Kjetil
Publicado: (2015)

Editorial: facts, figures and the future
por: Søreide, Kjetil
Publicado: (2015)

Service as joint editor-in-chief for 11 years comes to an end: adieu, godspeed and auf wiedersehn!
por: Søreide, Kjetil
Publicado: (2015)

Neoadjuvant and Adjuvant Therapy in Operable Pancreatic Cancer: Both Honey and Milk (but No Bread?)
por: Søreide, Kjetil
Publicado: (2021)

A formula for survival in surgery
por: Søreide, Kjetil
Publicado: (2023)

Metformin and Colorectal Cancer
por: Higurashi, Takuma, et al.
Publicado: (2018)

Scoring systems for outcome prediction in patients with perforated peptic ulcer
por: Thorsen, Kenneth, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_sjdajak3mmujectpu8qrg5l8g0